FDA issues boxing warning for Singulair


FAYETTEVILLE, Ark. (KNWA/KFTA) — The FDA is issuing its strongest warning for a popular asthma and allergy drug.

The agency has announced it’s issuing a “boxed warning” for Singulair.

The new label will advise doctors to avoid prescribing the medication for mild symptoms especially those with hay fever.

The drug has carried a warning since 2008 about a link with an increased risk of depression, sleeping problems, and suicidal thoughts.

However, the FDA said a review of data last year shows the risks may outweigh the benefits in some patients.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Latest Video

FOX24 Video


More News

Local News Video


More Don't Miss

Trending Stories

Follow KNWA & FOX24 on Facebook

get the app

News App

Weather App

Follow @KNWAFOX24 on Twitter

Mega Millions & Powerball Numbers